A combination of apple vinegar drink with Bacillus coagulans ameliorates high fat diet-induced body weight gain, insulin resistance and hepatic steatosis by Urtasun Alonso, Raquel et al.
nutrients
Article
A Combination of Apple Vinegar Drink with Bacillus
coagulans Ameliorates High Fat Diet-Induced Body
Weight Gain, Insulin Resistance and Hepatic Steatosis
Raquel Urtasun 1,† , Joana Díaz-Gómez 2,† , Miriam Araña 1 , María José Pajares 1,3,
María Oneca 1 , Paloma Torre 4, Maddalen Jiménez 5, Germán Munilla 2, Miguel Barajas 1,*,†
and Ignacio Encío 1,3,*,†
1 Biochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain;
raquel.urtasun@unavarra.es (R.U.); miriam.arana@unavarra.es (M.A.); mjose.pajares@unavarra.es (M.J.P.);
maria.oneca@unavarra.es (M.O.)
2 Ecovinal S.L., Pol. Ind Gobella, 1, 31589 Sartaguda, Spain; jdiaz@ecovinal.com (J.D.-G.);
gmunilla@ecovinal.es (G.M.)
3 Navarre’s Health Research Institute (IdiSNA), 31008 Pamplona, Spain
4 Nutrition and Bromatology area, Department of Natural Sciences, Public University of Navarre,
31006 Pamplona, Spain; paloma@unavarra.es
5 Division of Hematological-Oncology, CIMA, University of Navarre, 31006 Pamplona, Spain;
mjimenezan@unav.es
* Correspondence: miguel.barajas@unavarra.es (M.B.); ignacio.encio@unavarra.es (I.E.);
Tel.: +34-948-169-000 (M.B. & I.E.)
† These authors contributed equally to this work.
Received: 29 July 2020; Accepted: 17 August 2020; Published: 19 August 2020


Abstract: Obesity is a worldwide epidemic characterized by excessive fat accumulation, associated
with multiple comorbidities and complications. Emerging evidence points to gut microbiome
as a driving force in the pathogenesis of obesity. Vinegar intake, a traditional remedy source of
exogenous acetate, has been shown to improve glycemic control and to have anti-obesity effects. New
functional foods may be developed by supplementing traditional food with probiotics. B. coagulans
is a suitable choice because of its resistance to high temperatures. To analyze the possible synergic
effect of Vinegar and B. coagulans against the metabolic alterations induced by a high fat diet (HFD),
we fed twelve-week-old C57BL/6 mice with HFD for 5 weeks after 2 weeks of acclimation on a
normal diet. Then, food intake, body weight, blood biochemical parameters, histology and liver
inflammatory markers were analyzed. Although vinegar drink, either alone or supplemented with
B. coagulans, reduced food intake, attenuated body weight gain and enhanced glucose tolerance,
only the supplemented drink improved the lipid serum profile and prevented hepatic HFD-induced
overexpression of CD36, IL-1β, IL-6, LXR and SREBP, thus reducing lipid deposition in the liver.
The beneficial properties of the B. coagulans-supplemented vinegar appear to be mediated by a
reduction in insulin and leptin circulating levels.
Keywords: obesity; high fat diet; insulin resistance; hepatic steatosis; vinegar; Bacillus coagulans
1. Introduction
The prevalence of obesity has increased worldwide in the last ~50 years, reaching epidemic
proportions. Nowadays, it is one of the world’s greatest public health challenges because it comes
associated with metabolic complications such as dyslipidemia and insulin resistance with a consequent
risk of cardiovascular disease, non-alcoholic fatty liver disease (NAFLD) and other adverse health
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conditions [1]. Excess food intake, especially high-calorie diets, such as high-fat and high-sugar diets,
is considered the greatest risk factor in the development of obesity [2]. In addition, over the last decade,
different studies have been highlighting an increasingly more important role of the gut microbiota
in the development of obesity. Many studies have reported differences in microbiota composition
between obese and lean humans [3,4] and experimental studies have demonstrated that both short-and
long-term dietary change can influence our microbiota by reducing bacterial diversity and modifying
the microbial composition taxa [5]. However, potential mechanisms by which gut microbiota promote
metabolic disorders and obesity are still not well understood. Normally, dietary polysaccharides
that escape digestion in the small intestine are metabolized by the microbiota into short-chain fatty
acids (SCFA) during fiber digestion. The most abundant SCFA are acetate, propionate and butyrate.
Although some studies postulated that excess SCFA and bacterial genes related to polysaccharides
metabolism presented in feces are associated with the obese phenotype [6], new evidence has also
demonstrated that SCFA could also increase energy expenditure and anorexic hormone production and
support a beneficial role for SCFA in carbohydrates and lipid metabolism, contributing to improved
insulin sensitivity [7]. In addition, SCFA improve the gut health maintenance of intestinal barrier
integrity, mucus production and protection against inflammation [7].
So far, obesity treatments such as exclusively calorie reduced intake and/or bariatric surgery
modify the gut microbiota and are associated with health benefits. However, they have not
been completed successfully in the long term. Both present restricted benefits, mostly because
of complex and persevering hormonal response [8]. Consuming diets or foods with bioactive nutrients,
such as fermented foods, has been proposed as an effective solution to improve the effectiveness
of conventional treatments [9,10]. Some fermented foods are highly enriched in SCFA. Vinegar,
widely used as a flavouring and preservative in aliments, is a fermented drink enriched in bioactive
components such as acetic acid and polyphenolic compounds [11]. Besides, oral ingestion of vinegar
increases circulation of acetate [12]. Multiple functional properties of the vinegar are well established,
including antioxidant, anti-hyperglycaemia, anti-hypertension, anti-microbial, anti-thrombotic and
even anti-cancer properties [13]. Moreover, in the last decades, vinegar has captured some interest for its
beneficial effects on controlling body weight and visceral fat accumulation [11,14,15]. Mechanistically,
acetate has been found to block fatty acid synthesis and reduce lipid content in liver and adipose tissue,
improving obesity [16,17].
Potential sources of exogenous acetate include vinegar as well as the supplementation of
acetogenic fiber and probiotics or lactic acid bacteria [18]. Among lactic acid bacteria, Bifidobacterium
and Lactobacillus are the most studied and used probiotic microorganisms [19]. However, these
microorganisms cannot survive heat treatment. Bacillus spores can survive severe processing conditions
as well as tolerate and resist against the harsh conditions found in the gastrointestinal tract [20].
Although the use of probiotic strains of Bacillus is still recent, emerging studies have described the
health benefits associated with their ingestion [20,21]. For instance, probiotic strains of Bacillus were
shown to provide protective effects against high fat diet-induced metabolic disorders in mice [22]
and anti-obesity effects [23]. However, relatively few studies have examined the possible synergistic
effect between fermented foods and a specific Bacillus species. B. coagulans GBI-30 is a lactic producing,
spore forming, bacteria with GRAS (generally recognized as safe) status [20]. Authorized for human
usage, the strain, that transiently colonizes the intestine without the need for frequent consumption,
has already been proven to have beneficial effects in a variety of disorders, including irritable bowel
syndrome, colitis, rheumatoid arthritis, and common viral infections of the respiratory tract [24].
For this reason, the aim of this study was to investigate whether the combination of B. coagulans
GBI-30 with a heat-processed organic drink that contains apple cider vinegar, will be useful to prevent
the development of obesity and its metabolic alterations such as insulin resistance and fatty liver in a
mouse model of diet-induced obesity.
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2. Materials and Methods
2.1. Organic Vinegar Drink and Probiotic Strain
The organic vinegar drink was elaborated by Ecovinal S.L. (Sartaguda, Spain) and contains 5%
organic raw apple cider, unfiltered vinegar and fruit juices. The vinegar dose used in our animal study
was equivalent to the concentration of one tablespoon of vinegar diluted in 300 mL. This concentration
was selected based on previous animal studies considered as low dose [25,26] and the recommended
amount in human studies (1 tablespoon of vinegar per day) [27]. The complete nutritional analysis is
shown in Table 1. After heat-treatment, the vinegar drinks were stored at room temperature until used.
An organic drink of equal calorie content and formulation to apple vinegar drink without vinegar
(Vehicle) was also produced by Ecovinal S.L. (Sartaguda, Spain) for the experimental animal procedure.
Table 1. Nutritional analysis of organic apple vinegar drink.
Component Unit Amount
Energy value Kcal/100 mL 24
Energy value KJ/100 mL 100
Fat g/100 mL <0.05
Saturated Fat g/100 mL <0.05
Monounsaturated fat g/100 mL <0.05
Polyunsaturated fat g/100 mL <0.05
Trans fat g/100 mL <0.10
Total sugar g/100 mL 5
Glucose g/100 mL 2.1
Fructose g/100 mL 2.9
Sucrose g/100 mL <1
Maltose g/100 mL <1
Lactose g/100 mL <1
Fiber g/100 mL <0.05
Protein g/100 mL 0.11
Sodium mg/100 mL 8.7
Ash g/100 mL 0.18
Moisture g/100 mL 93.8
Freeze-dried spores of B. coagulans GBI-30 6086, kindly provided by Ganeden Inc. (Mayfield
Heights, OH, USA) were added to vinegar drinks in order to achieve 109–1010 spores per serving
of the drink product (200 mL), i.e., approximately 107–108 spores/mL. This dose was selected based
on two different rat studies that showed increased fecal SCFA [28] and no metabolic homeostasis
affectation [20].
2.2. Animal and Experimental Design
Eight-week-old male C57BL/6J mice were purchased from Charles River Laboratories. Mice were
maintained in a temperature (22 to 28 ◦C) and humidity-controlled room on a 12-h light/12-h dark
cycle with free access to food and drink during all of the study. In order to study the effect of vinegar
and B. coagulans in a diet-induced obesity mice model, mice at the age of 12 weeks and at an average
weight of 26.0 g, were randomly assigned into 5 groups (n = 6 mice per group). Each group had free
access to one of the following beverages:
(1) Water, (2) Organic drink without vinegar (Vehicle), (3) Vehicle with B. coagulans GBI-30 6086
(Vehicle_Bc), (4) Apple vinegar drink (Vinegar), (5) Apple vinegar drink supplemented with B. coagulans
GBI-30 6086. (Vinegar_Bc). The different groups were acclimatized for 2 weeks with a normal standard
pellet diet (ND).
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Then, group 1 remained on the ND while the other groups were fed with a High fat diet (HFD)
(60% Kcal from fat Teklad Diet TD.06414, Envigo, Madison, WI, USA) for 5 additional weeks, as shown
in the experimental design (Figure 1).
Nutrients 2020, 12, x FOR PEER REVIEW 4 of 20 
 
Then, group 1 remained on the ND while the other groups were fed with a High fat diet (HFD) 
(60% Kcal from fat Teklad Diet TD.06414, Envigo, Madison, WI, USA) for 5 additional weeks, as 
shown in the experimental design (Figure 1). 
During the experimental study, food and drink intake were recorded 2 times per week and body 
weight was measured weekly. Drink was changed every 3 days to minimize contamination. At the 
end of the experim nt l period (7 weeks), animals we e sacrific d by cervical dislocation after 
overnight fasting. All animal procedures were approved by the Institutional Committ  on Care and 
Use of Laboratory Animals (CEEA, University of Navarra, Protocol number: 028-18). 
 
Figure 1. Animal groups and experimental design used in the study. HFD: High fat diet, ND: Normal 
rodent diet. 
2.3. Fasting Blood Glucose and Tolerance Test 
Animals were fasted overnight, with free access to water prior to the test, and blood samples 
were obtained from the tip of the tail vein. Glucose concentrations were monitored using a pre-
calibrated glucometer (Accu-chek Aviva, Roche, Basel, Switzerland). Fasting blood glucose (FBG) 
was recorded once a week. 
In order to perform a glucose tolerance test (GTT), mice were fasted overnight, and 2 g/kg body 
weight of glucose was injected intraperitoneally. Measurement of blood glucose levels were 
performed at 0, 20, 40, 60, 90, and 120 min after glucose injection by collection of tail blood samples. 
The area under the curve (AUC) was assessed for each group from 0 to 120 min post glucose injection. 
The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), a widely used index for the 
assessment of insulin resistance [29], was calculated by the formula: HOMA-IR = serum C-peptide 
(nmol L−1) * serum glucose (mmol L−1)/22.5. 
2.4. Serum Biochemical Analysis 
Mice were fasted overnight before retro-orbital blood was drawn. Serum was obtained from 
blood samples after centrifugation for 15 min at 2200× g at 4 °C. Supernatant was collected and stored 
at −20 °C. Fasting serum cholesterol and triglycerides (TG) were determined using direct enzymatic 
colorimetric assays (Sigma-Aldrich, St. Louis, MO, USA). Total Free fatty acid (FFA) serum levels 
were quantified by means of a colorimetric assay using a commercial kit (Sigma-Aldrich, St. Louis, 
MO, USA). 
2.5. C-Peptide, GLP-1 and Leptin Analysis 
Figure 1. Animal groups and experimental design used in the study. HFD: High fat diet, ND: Normal
rodent diet.
During the experimental study, food and drink intake were recorded 2 times per week and body
weight was measured weekly. Drink was changed every 3 days to minimize contamination. At the end
of the experimental period (7 weeks), animals were acrificed by cervical dislocation after overnight
fasting. All animal procedures w re approved by the Institu ional Committee on Care and Use of
L bo ory Animals (CEEA, University of Navarra, Protocol number: 028-18).
2.3. Fasting Blood Glucose and Tolerance Test
Animals were fasted overnight, with free access to water prior to the test, and blood samples ere
obtained from the tip of the tail vein. Glucose concentrations were monitored using a pre-calibrated
glucometer (Accu-chek Aviva, Roche, Basel, Switzerland). Fasting blood glucose (FBG) was recorded
once a week.
In order to perform a glucose tolerance test (GTT), mice were fasted overnight, and 2 g/kg bo y
weight of glucose was injected intraperitoneally. Measurement of blood glucose levels were performed
at 0, 20, 40, 60, 90, and 120 min after glucose injection by collection of tail blood samples. The area under
the curve (AUC) was assessed for each group from 0 to 120 min post glucose injection. The Homeostasis
Model Assessment of Insulin Resistance (HOMA-IR), a widely used index for the assessment of insulin
resistance [29], was calculated by the formula: HOMA-IR = serum C-peptide (nmol L−1) * serum
glucose (mmol L−1)/22.5.
2.4. Serum Biochemical Analysis
Mice were fasted overnight before retro-orbital blood was drawn. Serum was obtained from
blood samples after centrifugation for 15 min at 2200× g at 4 ◦C. Supernatant was collected and stored
at −20 ◦C. Fasting serum cholesterol and triglycerides (TG) were determined using direct enzymatic
colorimetric assays (Sigma-Aldrich, St. Louis, MO, USA). Total Free fatty acid (FFA) serum levels
were quantified by means of a colorimetric assay using a commercial kit (Sigma-Aldrich, St. Louis,
MO, USA).
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2.5. C-Peptide, GLP-1 and Leptin Analysis
Serum C-peptide was assayed by sandwich ELISA method using an Ultra-Sensitive Mouse
C-peptide ELISA kit (Abyntek Biopharma, Derio, Spain). GLP-1 levels in serum were determined
using an ELISA kit (Sigma-Aldrich, St. Louis, MO, USA). Leptin levels were quantified using an
enzyme-linked immunosorbent assay ELISA kit (Sigma-Aldrich, St. Louis, MO, USA).
2.6. Quantitative Real-Time PCR (RT-qPCR)
Total RNA was extracted from the livers of mice using a RNeasy Mini kit (Qiagen, Germantown,
MD, USA). Then, cDNA synthesis (RT) was performed with RT Premix (Invitrogen, Carlsbad, CA,
USA). Quantitative real-time PCR (qPCR) were achieved using IQ SYBR green (Bio-Rad, Hercules,
CA, USA), in a CFX Connect TM Real-time system (Bio-Rad, Hercules, CA, USA) according to the
manufacturer’s instructions. The primer pairs used are listed in Table 2. The mRNA levels were
calculated as a ratio, using the 2−∆∆CT method, for comparing the relative mRNA expression levels
between different groups in the qPCR. All qPCRs were performed in triplicate and RPLPO gene was
used to normalize gene expression.































Gene full names. RPLPO: Ribosomal protein P0; LXR: Liver X receptor; CD36: Cluster of differentiation 36;
PPARα: Peroxisome proliferator.activated receptor; SREBP: sterol regulatory element-binding protein; FASN:
Fatty acid synthase; IL-1β: Interleukin 1 beta; IL-6: Interleukin 6; CPT-1: Carnitine palmitoyltransferase;
ACC: Acetyl-CoA-carboxylase.
2.7. Liver Histology and Morphometry
Tissue samples obtained from necropsy were fixed in 10% formalin for 24 h. The tissues were
dehydrated, paraffin-embedded and processed for hematoxylin and eosin (H&E) staining. Digital
images (ten per liver section) were acquired randomly with a 40× objective using a digital camera
coupled to a conventional microscope (Olympus CH, Shinjuku, Japan).
The morphometric estimation of hepatic steatosis was analyzed with ImageJ software using
digital images obtained and data expressed as a percentage of the area occupied by lipid droplets.
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For the quantification of the macrovesicular steatosis, two different observers, who were blinded for
the treatment applied to each animal, individually examined the images and visually determined the
percentage of hepatocytes containing macrovesicular lipid droplets. Macrovesicular steatosis was
defined as lipid droplets larger than the cell nucleus.
2.8. Triglyceride Liver Content
First, liver tissue was homogenized in a 5% Nonidet P40 solution. After heating the samples to
100 ◦C in a water bath for 5 min, they were cooled to room temperature. Triglyceride content in the
liver extracts was then determined using a Triglyceride Quantification Kit (Sigma-Aldrich, MO, USA).
Obtained values were normalized with protein liver content.
2.9. Statistical Analysis
Data were expressed as the mean ± standard deviation (SD). Statistical analysis was performed
using GraphPad Prism version 8 (GraphPad, La Jolla, CA, USA). The statistical analysis of body
weight evolution and glucose tolerance test were performed by two-way repeated measures ANOVA
followed by Bonferroni post hoc test. For all other data, one-way analysis of variance ANOVA or
Kruskal–Wallis test followed by Tukey’s multiple comparison test was performed. The Student’s t or
Mann–Whitney U test was used for the two groups’ comparisons. p values < 0.05 were considered as
statistically significant.
3. Results
3.1. Vinegar Drink Either Alone or in Combination with B. coagulans Attenuated High Caloric Diet-Induced
Weight Gain
In this study, we examined the effect of an Apple vinegar drink, either alone or in combination
with B. coagulans, in mice fed with a HFD. For this purpose, male C57BL/6 mice were divided into five
groups (six mice per group) with free access to the above described drinks of equal calorie content,
except for the ND group (water control group) (Figure 1). During the entire HFD feeding period, mice
body weight was significantly higher in every HFD group than in the ND group (Figure 2A). Though
increased, total body weight at the end of the experimental procedure showed lower increments in the
HFD+Vinegar and HFD+Vinegar_Bc groups than in the non-vinegar obese mice group (HFD+Vehicle)
(p < 0.05). This significant attenuation of total body weight was already observed from week 5 of
the experimental design (Figure 2A). In accordance with this result, an increase in body weight gain
in mice fed with HFD (p < 0.001) was observed at the end of the experimental period (Figure 2B),
and a significant reduction in this increase was observed in the HFD+Vehicle_Bc, HFD+Vinegar,
HFD+Vinegar_Bc groups when compared to their corresponding control obese mice (HFD+Vehicle)
(p < 0.05 for all except p < 0.01 for HD+Vinegar_Bc) (Figure 2B).
Mean energy intake was estimated by converting the amount of food and drink consumed into
calories using the information provided by the Tekland diet manufacturer (Envigo, Madison, WI, USA)
and the calorie content of the vinegar drink (Table 1). As shown in Figure 2C, daily energy intake
was higher in HFD mice than in the ND mice (p < 0.001). However, this increase was significantly
smaller in HFD+Vehicle_Bc, HFD+Vinegar and HFD+Vinegar_Bc groups than in the HFD+Vehicle
group (p < 0.05, p < 0.05, p < 0.01, respectively). This result may be attributable to a reduction in
mice food intake, as the daily food consumption (grams) in HFD+Vehicle_Bc, HFD+Vinegar and
HFD+Vinegar_Bc was lower than in the HFD+Vehicle and ND groups (p < 0.05, p < 0.05, p < 0.001,
respectively) (Figure 2D). However, there were no significant differences between HFD groups in drink
intake (not shown), nor in the metabolic efficiency ratio (body weight gain relative to mean energy
intake) among the HFD groups (Figure 2E).
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Figure 2. Effect of the different drinks on body weight, weight gain, food and calorie intake in
HFD-induced obese mice. (A) Changes in body weight during the animal experimental study,
(B) Differences in body weight gain between groups, (C) Daily energy intake calculated by converting
the amount of food and drink consumed into calories, (D) Differences in food intake (g/mouse/day)
between groups, (E) Metabolic or food efficiency ratio represented as the body weight gain relative to
energy intake. Abbreviations. ND: Normal diet; HFD: High fat diet; ND+Water: Normal diet plus
water; HFD+Vehicle: High fat diet plus vehicle (non-vinegar), HFD+Vehicle_Bc: High fat diet plus
vehicle and B. coagulans; HFD+Vinegar: High fat diet plus vinegar; HFD+Vinegar_Bc: High fat diet
plus vinegar and B. coagulans. Data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001
vs. ND group, # p < 0.05, ## p < 0.01 ### p < 0.001 vs. HFD+Vehicle. (n = 6 mice per group).
3.2. Vinegar Drink Either Alone or in Combination with B. coagulans Improves Glycemic and Glucose Tolerance
To explore the effect of vinegar ± B. coagulans on glucose homeostasis, basal serum glucose was
measured at several time points during the experimental procedure, and a GTT was performed at
the end of the experimen . No significant changes were detected in serum glucose level among the
groups before w ek 4 of the experimental study. However, at w ek 4 ll HFD groups displ yed
higher basal glucose levels than the ND group (p < 0.001 for HFD+Vehicle, HFD+Vehicle_Bc and
HFD+Vinega _Bc groups, p < 0.05 fo HFD+Vinegar) (Figure 3A). Int resting y, after seven weeks only
t e HFD+Vehicle and HFD+Vehicle_Bc exhibited higher fasting glucos levels than the ND group
(p < 0.01). Moreover, significantly smaller fasting blood glucose levels were fou d in the HFD+Vinegar
and HFD+Vinegar_B mice than in the HFD+V hicle group (p < 0.05) (Fi ure 3A).
In regard to the GTT performed at week 7, as expected, basal serum glucose concentration was
higher in the HFD+Vehicle and HFD+Vehicle_Bc mice than in the ND grou (p < 0.01). In contrast,
the basal glucose concentration in HFD+Vin gar nd HFD+Vinegar_Bc group was l wer th n i the
HFD+Vehicle group (p < 0.05) (Figure 3B). Peak levels of glucose w re reached in every group 20 min
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after the intraperitoneal administration of glucose. Glucose levels remained higher in the HFD+Vehicle
mice than in the ND mice 40, 60, 90 and 120 min after injection (p < 0.001) (Figure 3B).
In contrast, glucose levels in the HFD+Vinegar and HFD+Vinegar_Bc groups decreased faster
from minute 60 to 120, normalizing their values compared to HFD+Vehicle (p < 0.01). A trend towards
normalization was also observed in the HFD+Vehicle_Bc mice, though in this case the decrease did not
reach statistical significance (Figure 3B). Besides, the area under the curve (AUC) was greater in all
HFD mice than in the ND mice (p < 0.001 for HFD+Vehicle, and p < 0.01 for the rest of HFD groups)
(Figure 3C), indicating impaired glucose tolerance. However, HFD+Vehicle_Bc, HFD+Vinegar and
HFD+Vinegar_Bc presented smaller AUC than the HFD+Vehicle mice (p < 0.05, p < 0.01, p < 0.01,
respectively), pointing to a better glucose tolerance for mice in these groups than for those in the HFD
control group (Figure 3C).
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Figure 3. Vinegar and B. coagulans improved glucose homeostasis. (A) Fasting blood glucose measured
at several time points during the experimental procedure, (B) Blood glucose levels in response to
glucose tolerance test at week 7, (C) Effect on area under the curve (AUC). Abbreviations. ND: Normal
diet; HFD: High fat diet; ND+Water: Normal diet plus water; HFD+Vehicle: High fat diet plus vehicle
(non-vinegar), HFD+Vehicle_Bc: High fat diet plus vehicle and B. coagulans; HFD+Vinegar: High fat
diet plus vinegar; HFD+Vinegar_Bc: High fat diet plus vinegar and B. coagulans. Data are expressed as
mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. ND, # p < 0.05, ## p < 0.01 vs. HFD+Vehicle group.
(n = 6 mice per group).
3.3. Vinegar Drink Together with B. coagulans Attenuates Dislipidemia in Obese Mice
To assess the effect of vinegar ± B. coagulans on lipid profile in mice fed HFD, triglycerides,
cholesterol and free fatty acids (FFA) levels were determined in serum. After 5 weeks of HFD feeding,
a significant increase in serum triglyceride levels was quantified in HFD+Vehicle and HFD+Vinegar
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groups compared to the ND group (p < 0.05), thus suggesting the onset of dyslipidemia by HFD
feeding (Figure 4A). As shown in the figure, supplementation of HFD with Vinegar and B. coagulans
prevented this increase (HFD+Vinegar_Bc vs. HFD+Vehicle: p < 0.05).
In this dyslipidemic condition, cholesterol levels were significantly higher in all HFD groups
(HFD+Vehicle, HFD+Vehicle_Bc, HFD+Vinegar, HFD+Vinegar_Bc) than in the ND group (p < 0.001
for HFD+Vehicle and p < 0.05 for the rest of the HFD groups). Only the HFD+Vinegar_Bc group
significantly ameliorated cholesterol levels compared to the HFD+Vehicle group (p < 0.05) (Figure 4B).
In addition, there were no significant differences in fasting serum FFA between the HFD+Vehicle,
HFD+Vehicle_Bc, HFD+Vinegar and ND groups. However, a significant reduction was found in
FFA serum concentration of the HFD+Vinegar_Bc when comparing it to the control group (p < 0.05)
(Figure 4C).
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Figure 4. Serum lipid profile in HFD-fed mice supplemented with vinegar and non-vinegar drinks ±
B. coagulans for 5 weeks. (A) Concentration of serum Triglycerides (TG), (B) Serum total cholesterol,
(C) and serum free fatty acids (FFA) on mice fed ND or HFD, respectively. Abbreviations. ND: Normal
diet; HFD: High fat diet; ND+Water: Normal diet plus water; HFD+Vehicle: High fat diet plus vehicle
(non-vinegar), HFD+Vehicle_Bc: High fat diet plus vehicle and B. coagulans; HFD+Vinegar: High fat
diet plus vinegar; HFD+Vinegar_Bc: High fat diet plus vinegar and B. coagulans. Values are expressed
as the mean ± SD. * p < 0.05, *** p < 0.001 vs. ND, # p < 0.05 vs. HFD+Vehicle group. (n = 6 mice per
group).
3.4. Vinegar Supplemented with B. coagulans Ameliorated Fat Liver Accumulation: Histological Assessment of
the Liver
Photomicrographs of liver tissue for all animal experimental groups are shown in (Figure 5A).
At the end of the animal study, the liver tissue of ice fed with ND presented a n rmal architecture of
hepatocytes, with o appearance of lipid droplet deposition (Figure 5A). In contrast, HFD-fed mic
showed fat droplet deposition consisting of mixed micr vesicular and macrovesicular steatosis, while
vinegar and B. coagulans, alone or in combination, re a kably suppressed vacuole forma ion and
lip d accumulation in hepatocytes (Figure 5A). The h stopathological q antification sh wed a higher
degree of macrovesicular steatosis in HFD+Vehicle mic than in e ND group (p < 0.01) (Figur 5B).
Interestin ly, vineg r drink, B. coagulan and the combination of both exhibited less macrovesicular
deposition, though a statistically significant chan e was observed only in the HFD+Vehicle_Bc group
(p < 0.05) (Figure 5B). The quantification of liver micro and macrovesicular teatosis yielded a higher
number of vesi les in the HFD+Vehicle group t an in the ND (p < 0.05) (F gure 5C). Fo th rest of
the HFD groups, no significant differences in micro and macrovesicular steatosis with the ND group
were found (Figur 5C). Consistent with this histological an morphological observation, hepatic TG
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accumulation appeared to be higher in mice fed with HFD compared to ND (p < 0.01 for HFD+Vehicle,
and p < 0.05 for the rest of the HFD groups) (Figure 5D). Supplementation of HFD with vinegar,
B. coagulans, or their combination did not significantly counteract hepatic TG accumulation, although a
trend towards a decrease was observed in every case. In summary, our results showed that vinegar,
and B. coagulans alone or in combination, may reduce fat liver accumulation induced by the HFD and
improve liver steatosis.
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3.5. Vinegar Drink Together with B. coagulans Ameliorates the Expression of Altered Lipid Metabolism-Related
and Pro-Inflammatory Genes in the Livers of High Fat Diet Mice
Fatty liver occurs when fat accumulation is caused by impaired fatty acid oxidation along with
increased lipid synthesis. To understand the molecular mechanisms underlying the protective effect
observed in the liver for the vinegar drink supplemented with B. coagulans, we next evaluated the
expression in liver tissue of lipid metabolism-related genes, such as lipogenic genes, fatty acid synthesis
genes or fatty acid oxidation genes (Figure 6). As shown in the Figure, at the end of the experimental
study we found a significant increase in the expression of the adipogenesis-related gene CD36 in
the liver of mice fed with HFD+Vehicle compared to mice fed with ND (p < 0.01). Figure 6A also
shows that supplementation of HFD with either vinegar, B. coagulans or both prevented HFD from
inducing long chain fatty acid receptor CD36 expression (p < 0.05 compared to HFD+Vehicle), thereby
attenuating fatty acid uptake in the liver. Similar results were found when looking for LXR sensor
of cholesterol metabolism and lipid biosynthesis expression: LXR mRNA expression was higher
in the HFD+Vehicle, HFD+Vehicle_Bc and HFD+Vinegar groups than in the ND group (p < 0.01).
However, supplementation of HFD with Vinegar + B. coagulans prevented induction of LXR by HFD
(HFD+Vinegar_Bc vs. HFD+Vehicle: p < 0.01) and maintained normal LXR expression levels.
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Figure 6. Effect of vinegar ± B. coagulans on mRNA levels of hepatic genes. (A,B) Effect of vinegar ±
B. coagulans on mRNA levels of several genes involved in hepatic lipogenesis and β-oxidation, (C) Effect
of vinegar ± B. coagulans on mRNA expression levels of pro-inflammatory cytokines in the liver. Total
RNA extracted from the liver was reverse transcribed, and each gene expression was quantified by
real-tim PCR using ge -specific primers. All genes wer r alized to expressi n of RPLPO. The
relative xpr ssion level of each gene was calculated as th change from the triplicates in each
group using the 2−∆∆Ct method. -axis repr sents the relative expression of the studied genes.
Gene full names. RPLPO: Ribosomal protein P0; LXR: Liver X receptor; CD36: Cluster of differentiation
36; PPARα: Peroxisome proliferator activated receptor; SREBP: sterol regulatory element-binding
protein; FASN: Fatty acid synthase; IL-1β: Interleukin 1 beta; IL-6: Interleukin 6; CPT-1: Carnitine
palmitoyltransferase; ACC: Acetyl-CoA-carboxylase. Abbreviations. ND: Normal diet; HFD: High
fat diet; ND+Water: Normal diet plus water; HFD+Vehicle: High fat diet plus vehicle (non-vinegar),
HFD+Vehicle_Bc: High fat diet plus vehicle and B. coagulans; HFD+Vinegar: High fat diet plus vinegar;
HFD+Vinegar_Bc: High fat diet plus vinegar and B. coagulans. Data are expressed as mean ± SD.
* p < 0.05, ** p < 0.01 vs. control, # p < 0.05, ## p < 0.01 vs. HFD+Vehicle group. (n = 6 mice per group).
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Plasma fatty acid taken up by the liver is further augmented by increased hepatic de novo
lipogenesis. LXR directly regulates the expression of genes involved in fatty acid synthesis including
SREBP, a master regulator of fatty acid synthesis. Thus, not surprisingly, HFD feeding induced a
significant upregulation of SREBP in mice fed with HFD+Vehicle (HFD+Vehicle vs. ND: p < 0.01)
(Figure 6B). Upregulation was attenuated by both vinegar and B. coagulans, though only reached
statistical significance when the two were present (HFD+Vinegar_Bc vs. HFD+Vehicle: p < 0.01)
(Figure 6B).
Regulation of de novo lipogenesis occurs too by the regulation of various key enzymatic activities,
including FAS and ACC among others. Analysis of the hepatic expression of these genes revealed
no statistically significant differences in ACC expression among groups (Figure 6B). However, HFD
feeding increased FAS expression (HFD+Vehicle vs. ND: p < 0.05). In this case, neither vinegar
nor B. coagulans supplementation led to a significant attenuation of HFD-induced FAS expression
(Figure 6B).
Several studies have shown that PPARα expression is activated by fatty acids. This is especially
important during fasting, when plasma FFAs and the flux of fatty acids through the liver increase
dramatically [30]. Accordingly, in our experimental study HFD feeding induced a significant
upregulation of PPARα compared to ND (p < 0.05), and in consonance with the reduction in FFA serum
concentration described above, HFD-induced PPARα upregulation was prevented by HFD+Vinegar_Bc
(HFD+Vinegar_Bc vs. HFD+Vehicle: p < 0.05) (Figure 6B). Besides, HFD feeding impaired the fatty
acid oxidation pathway as pointed out by the slight decrease observed in mRNA abundance of CPT1
in HFD-fed mice, which was restored in HFD+Vehicle_Bc and HFD+Vinegar, although this last result
did not reach statistical significance (Figure 6B).
Obesity is closely associated with an increased risk of NAFLD that includes a disease spectrum that
ranges from steatosis or isolated fatty liver to non-alcoholic steatohepatitis (NASH), a more aggressive
form that can progress to fibrosis, cirrhosis and hepatocarcinoma [31]. Numerous studies have reported
complex interactions between obesity, hepatic steatosis and chronic inflammation. In addition, adipose
tissue dysfunction and the hepatic inflammatory response have an important role in the transition from
isolated fatty liver or steatosis to NASH. To examine whether vinegar drink ± B. coagulans improved
liver inflammation in HFD-fed mice, the amount of mRNA of pro-inflammatory cytokines in the
liver was determined. As shown in Figure 6C, HFD feeding induced a significant up-regulation of
IL-1β and IL-6 mRNA (HFD+Vehicle vs. ND: p < 0.001 and p < 0.05, respectively). Supplementation
of HFD with either vinegar, B. coagulans or both prevented Il-1β upregulation (HFD+Vehicle_Bc
vs. HFD+Vehicle, p < 0.05, HFD+Vinegar vs. HFD+Vehicle: p < 0.01, and HFD+Vinegar_Bc vs.
HFD+Vehicle: p < 0.01) in the liver (Figure 6C). Similarly, liver mRNA expression of IL-6 was
significantly reduced in HFD+Vinegar and HFD+Vinegar_Bc mice, compared with HFD+Vehicle mice
(p < 0.001 and p < 0.05, respectively) (Figure 6C).
3.6. Effect of Vinegar Drink and B. coagulans on Leptin, GLP-1 and Insulin Levels in Serum
Emerging evidence has shown an important role of the microbiota–gut–brain axis in the control of
food intake by the hypothalamus and in insulin and leptin signaling in the contribution to evolution of
obesity [32]. As mentioned before, mice fed with a HFD supplemented with vinegar ± B. coagulans
gained less weight and had reduced food intake than non-vinegar HFD-fed mice. For this reason,
we explored whether vinegar ± B. coagulans improved the response to anorexigenic hormones such as
leptin, insulin and glucagon-like peptide 1 (GLP-1) in serum of HFD-fed mice.
Apart from the well-known effect of fasting GLP-1 as an anorexic hormone able to reduce appetite
and food intake [33], growing evidence has suggested that the reduction in plasma GLP-1 levels
is related to disorders of glucose homeostasis [34]. In addition, recent studies have demonstrated
that fasting circulating SCFA (acetate) are related to insulin sensitivity, lipolysis and fasting GLP-1
concentration in human blood [35]. To understand whether the mechanism underlying the effect of
vinegar and B. coagulans to inhibit food intake and improve glucose homeostasis, could be related to the
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production of this anorexic hormone, fasting serum GLP-1 levels were explored. Figure 7A shows that
mice receiving HFD had reduced serum fasting GLP-1 concentration than ND mice (p < 0.05). Neither
vinegar nor B. coagulans supplementation counterparted this effect. However, no significant differences
in fasting serum GLP-1 level were detected between the HFD+Vinegar_Bc and ND mice (Figure 7A).Nutrients 2020, 12, x FOR PEER REVIEW 14 of 20 
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Figure 7. Effect of vinegar ± B. coagulans on GLP-1, Leptin and C-peptide in serum. (A) Fasting
serum GLP-1, (B) Fasting serum leptin, (C) Fasting C-peptide levels, (D) Insulin sensibility estimated
using average HOMA-IR in each group calculated from fasting serum glucose and fasting serum
C-peptide concentrations with the formula: serum C-peptide (nmol L−1) * serum glucose (mmol
L−1)/22.5. Abbreviations. ND: Normal diet; HFD: High fat diet; ND+Water: Normal diet plus water;
HFD+Vehicle: High fat diet plus vehicle (non-vinegar), HFD+Vehicle_Bc: High fat diet plus vehicle
and B. coagulans; HFD+Vinegar: High fat diet plus vinegar; HFD+Vinegar_Bc: High fat diet plus
vinegar and B. coagulans Data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. ND
group, # p < 0.05, ### p < 0.001 vs. HFD+Vehicle. (n = 6 mice per group).
As shown in Figure 7B, HFD mice exhibited significantly higher levels of leptin in serum than
ND mice (p < 0.001 for HFD+Vehicle and HFD+Vinegar, p < 0.05 for the rest of the HFD groups),
indicating leptin resistance in HFD-fed mice. Supplementation of HFD with either vinegar, B. coagulans
or both decreased leptin serum levels (HFD+Vehicle_Bc vs. HFD+Vehicle: p < 0.001, HFD+Vinegar
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vs. HFD+Vehicle: p < 0.05, and HFD+Vinegar_Bc vs. HFD+Vehicle: p < 0.001), suggesting that the
administration of vinegar ± B. coagulans to HFD mice improved leptin sensibility as evidenced by
reduced food intake.
As shown before, the mean values of AUC obtained during GTT were greater in HFD-fed mice,
thus indicating insulin resistance. In accordance with this, fasting serum C-peptide levels were elevated
in HFD mice compared to ND mice (p < 0.001 for HFD+Vehicle, p < 0.01 for HFD+Vehicle_Bc and
p < 0.05 for HFD+Vinegar and HFD+Vinegar_Bc) (Figure 7C). Supplementation of HFD with vinegar
attenuated elevation (HFD+Vinegar and HFD+Vinegar_Bc groups vs HFD+Vehicle: p < 0.05). These
results partially correlated with the insulin resistance index based in C-peptide (HOMA-IR) that
showed a significant increase in all HFD-fed groups when compared to the ND mice (p < 0.01 for
HFD+Vehicle and p < 0.05 for the rest of HFD groups). However, the resistance index was not restored
by vinegar, B. coagulans, or their combination, although a trend towards a decrease was observed in
every case (Figure 7D).
4. Discussion
Obesity is a prevalent health issue worldwide [36,37]. Associated with modernization, it affects
physical activity and food habits. Consuming high fat diets has been identified as the main important
reason for the increased risk of developing obesity [2]. Initially, apart from genetics and environmental
factors, obesity was only attributed to a prolonged imbalance between energy intake and energy
expenditure [38]. Nowadays, numerous studies in mice and humans have also shown that obesity is
associated with changes in the diversity and abundance of the microbiota [5,6]. In addition, growing
evidence has demonstrated that the microbiota may impact body weight gain and adiposity through a
network of interconnected pathways, such as energy harvest and production of microbial metabolites,
inflammatory response, and effects on the gut–brain axis. SCFA metabolites participate in this complex
signaling [7].
Fermented foods, especially vinegars produced for different fruits, have long being consumed
worldwide to obtain different health benefits, including body weight control [11]. Vinegar is considered
a dietary source of acetate, due to its ingestion acetate levels in plasma increasing rapidly [39].
Nowadays, new functional foods are increasing their popularity due to their wide-range and long-term
benefits [40]. Specially, people are interested in weight loss shifting away from “magic pills” and
traditional weight loss programs to more natural and healthier alternatives. In line with this idea,
the purpose of this study was to explore the role of a new functional drink, obtained from an organic
apple vinegar beverage inoculated with the spore-forming B. coagulans as a probiotic in diet-induced
obese mice.
B. coagulans is an ideal choice to develop functional foods because of its resistance to high
temperatures. Although, there are still few studies showing the effect of B. coagulans on microbiota,
several beneficial effects have been reported. Recently, it has been published that the administration of
B. coagulans to rats resulted in a drastic increase in acetate and butyrate in rat feces, with a relatively
higher level of total SCFA compared to untreated control rats [28]. In the present study, we found
that both vinegar drink alone and vinegar drink supplemented with B. coagulans improved glucose
tolerance and prevented body weight gain in a mice model of HFD-induced obesity. It is worth
noting that we also found a protective effect on lipid profile, decreased expression of genes involved
in lipogenesis, and a reduction in macrovesicular hepatic steatosis only when the organic drink was
supplemented with both vinegar and B. coagulans. The ability of B. coagulans to increase intestinal
acetate and butyrate concentrations [28], thus improving the effect of vinegar, is a likely explanation
for this finding.
In the search for the mechanism involved in the control of weight gain, the impact of vinegar
and B. coagulans on plasma leptin, insulin and Glucagon-like peptide 1 (GLP-1) was explored. GLP-1
is known for its glucoregulatory and appetite-suppressing effects, playing an important role in the
regulation of food intake and insulin secretion [41]. Several studies have demonstrated that high fat
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diets impair the secretory function of GLP-1-producing cells [42,43]. More concretely, a reduction in
GLP-1 expression was observed in diet-induced obese mice characterized by mitochondrial stress
in colon enterocytes [44]. By contrast, in enteroendocrine L-cells, SCFA increase GLP-1 expression
and secretion by activation of GRP43, mainly by the effect of dietary fibers [45]. According to these
observations, we detected a reduction in fasting serum GLP-1 in HFD-induced obese mice. Interestingly,
fasting serum GLP-1 levels were not reduced in HFD+Vinegar_Bc-induced obese mice, which suggests
that GLP-1 regulation of appetite is involved in the effect of vinegar and B. coagulans on food intake and
body weight. Thus, B. coagulans-derived SCFA, likely acetate, may contribute to the vinegar activity in
the regulation of GLP-1 in vivo, although this needs further investigation.
Leptin is mainly produced by adipocytes, and serum HFD-induced levels of leptin correlate with
adipocyte fat storage [46]. Acting in hypothalamic centers, major roles of leptin are the regulation
of food intake and increasing energy expenditure. Leptin resistance occurs in response to high fat
diets. In obesity, circulating levels of leptin rise, although its ability to reduce food intake and to
increase energy expenditure diminishes; hyperleptinaemia and inflammation have been postulated
as causative mechanisms [47]. Using different mouse models, Koch et al. demonstrated: first, that
6-weeks treatment of obese wild type mice with a leptin neutralizing antibody drives a 10% reduction
in food intake; second, that hyperleptinaemia is a driving force of metabolic disorders; third, that a
partial restoration of leptin levels in plasma leads to improved leptin sensibility and insulin sensitivity,
and reduces weight gain and hepatic steatosis [48]. Recently, the same authors reported that preserving
lower leptin levels in an obesogenic environment is highly beneficial for obesity and diabetes control.
In this last study, partial leptin deficiency led to a better leptin sensibility in HFD mice, as assessed
by an overall reduced food intake [49]. In concordance with these studies, in this work we found
that a vinegar drink, either alone or supplemented with B. coagulans, partially reduced circulating
leptin levels, improved glucose tolerance, decreased C-peptide levels in serum, and improved the
insulin sensitivity index in HFD-induced obese mice. Normally, lower body weight and better glucose
tolerance correlate positively, both in animal models and in human clinical studies. For this reason,
we speculate that the observed beneficial effects obtained with vinegar and B. coagulans, such as
improved glucose tolerance and even reduced fatty liver, could be in part explained by its ability to
restore leptin sensibility, thus reducing food intake and body weight gain.
Fatty liver disease is associated with insulin resistance and obesity and may be considered as the
hepatic manifestation of metabolic syndrome. While the physiopathology of the non-alcoholic fatty
liver disease (NAFLD) is not fully understood, steatosis is considered as a key initial event. Lipotoxicity,
insulin resistance and inflammation are essential players in the progression towards a non-alcoholic
liver steatohepatitis (NASH), the more aggressive form of NAFLD [50]. Obesity-associated chronic
inflammation is known to be responsible for the impaired insulin response. However, the role of
pro-inflammatory cytokines in NAFLD is still unclear, although several studies have demonstrated
that TNFα, IL-1β and IL-6 are important mediators in the development of NAFLD. In addition to their
expected role as pro-inflammatory cytokines in inflammation, they promote steatosis, inflammation
and fibrosis. For instance, IL-1β can stimulate the production of TNFα and IL-6, and increases
the accumulation of triglycerides and cholesterol [51]. In the present work, we found that vinegar
supplemented with B. coagulans improved the lipid profile and suppressed hepatic steatosis induced
by HFD in mice. This protective effect seems to be mediated by a reduction in the hepatic expression of
CD36, a protein involved in fatty acid uptake. Disruption of hepatic CD36 has been shown to reduce
both lipid content and free fatty acid uptake in the liver of HFD-fed mice, and also to protect against
associated systemic inflammation and insulin resistance [52]. According to these results, we also found
that vinegar, B. coagulans and their combination suppressed the HFD-induced overexpression of IL-1β
and IL-6 inflammatory cytokines in the liver. They also reduced HFD-induced overexpression of SREBP
and LXR transcription factors. LXR is a nuclear receptor that controls lipid metabolism by regulating
the expression of SREBP and other genes involved in hepatic lipogenesis in NAFLD [53]. In the liver,
SREBP is involved in the biogenesis of cholesterol, fatty acids and triglycerides; it also has a role in the
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pathogenesis of NAFDL and NASH [54]. Activated by downstream signaling, SREBP increases FAS
mRNA expression, which collaborates in fatty acids synthesis. Down-regulation of SREBP expression
is thus a likely explanation for the reduction in both fat accumulation in the liver and cholesterol and
triglycerides levels in serum observed in the HFD+Vinegar_Bc mice. Additionally, activation of LXR
has also been described to have anti-inflammatory effects in steatosis [55,56]. Therefore, the reduction
in LXR expression could reflect the effect of vinegar and B. coagulans on systemic inflammation. All
together, these results are consistent with the alleviated liver hepatic fat accumulation induced by
vinegar and B. coagulans in our mice model of diet-induced obesity
In the context of NAFLD, hepatic steatosis can be stimulated via increased fatty acid uptake,
increased de novo lipogenesis and failed fatty acid oxidation. In the present work, we did not find
a clear modulation of the hepatic expression of the lipogenic genes FAS and ACC by vinegar and
B. coagulans. In contrast, our data show that vinegar and B. coagulans, independently, tended to enhance
hepatic oxidation since they prevent the HFD-induced down-regulation of CPT1. Surprisingly, the
expression of PPARα, a gene known to promote fatty acid oxidation, was increased in every HFD-fed
group except for the HFD+Vinegar_Bc mice. Since hepatic fasting has been shown to induce PPARα
expression [57] and considering that we collected liver hepatic tissue after an eight-hour fast, our
animal experimental procedure could be the reason for this result. For this reason, further experiments
are needed to better characterize the action of vinegar and B. coagulans on the beta-oxidation pathway
in the liver.
5. Conclusions
In summary, our study demonstrates that a new functional organic drink containing apple cider
vinegar reduced food intake, attenuated body weight gain and enhanced glucose tolerance. Moreover,
when supplemented with B. coagulans at a concentration of approximately 107–108 spores/mL, the drink
also improved the lipid serum profile and prevented hepatic steatosis induced by HFD in mice. This
protective effect was mediated by a reduction in the hepatic expression of CD36, IL-1β, IL-6, LXR and
SREBP, which alleviated fat accumulation in the liver. The ability of the vinegar drink to partly restore
leptin and insulin sensibilities could explain its beneficial effects. Further experiments are needed to
confirm whether B. coagulans-derived SCFA contribute or not to the vinegar activity.
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